In mice with diet-induced atherosclerosis treatment with a RANTES chemokine antagonist, hereby blocking CCR5, reduced atherosclerotic plaque formation, associated with reduced proliferation and secretion of Th1 cytokines IFN-γ and TNF-α, without difference in Th2 cytokine profile [27]. This evidence concerns the gene CCL5 and atherosclerosis.